These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 12052284)

  • 41. Antiplatelet Therapy vs Anticoagulation Therapy in Cervical Artery Dissection: The Cervical Artery Dissection in Stroke Study (CADISS) Randomized Clinical Trial Final Results.
    Markus HS; Levi C; King A; Madigan J; Norris J;
    JAMA Neurol; 2019 Jun; 76(6):657-664. PubMed ID: 30801621
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mixed treatment comparison meta-analysis of aspirin, warfarin, and new anticoagulants for stroke prevention in patients with nonvalvular atrial fibrillation.
    Assiri A; Al-Majzoub O; Kanaan AO; Donovan JL; Silva M
    Clin Ther; 2013 Jul; 35(7):967-984.e2. PubMed ID: 23870607
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Atrial fibrillation and stroke prevention.
    Lip GY; Lim HS
    Lancet Neurol; 2007 Nov; 6(11):981-93. PubMed ID: 17945152
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment for the secondary prevention of stroke in older patients: the influence of dementia status.
    Moroney JT; Tseng CL; Paik MC; Mohr JP; Desmond DW
    J Am Geriatr Soc; 1999 Jul; 47(7):824-9. PubMed ID: 10404926
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Design, progress and challenges of a double-blind trial of warfarin versus aspirin for symptomatic intracranial arterial stenosis.
    Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Trial Investigators
    Neuroepidemiology; 2003; 22(2):106-17. PubMed ID: 12656117
    [No Abstract]   [Full Text] [Related]  

  • 46. Warfarin or aspirin for recurrent ischemic stroke.
    Algra A;
    N Engl J Med; 2002 Apr; 346(15):1169-71. PubMed ID: 11951857
    [No Abstract]   [Full Text] [Related]  

  • 47. [Prevention of recurrent ischemic stroke: recent clinical trial results].
    Mohr JP
    Neurologia; 2002; 17(7):378-82. PubMed ID: 12236957
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical implication of antiembolic trials in atrial fibrillation and role of transesophageal echocardiography in atrial fibrillation.
    Jagasia DH; Williams B; Ezekowitz MD
    Curr Opin Cardiol; 2000 Jan; 15(1):58-63. PubMed ID: 10666662
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antiplatelet versus anticoagulant therapies in advanced age: an unfinished task.
    García-Honrubia A; Roldán V; Climent V; Sogorb F; Marín F
    Int J Cardiol; 2006 Jun; 110(2):271-2. PubMed ID: 16343666
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aspirin and warfarin equally good for stroke patients.
    Gottlieb S
    BMJ; 2001 Nov; 323(7323):1204. PubMed ID: 11719405
    [No Abstract]   [Full Text] [Related]  

  • 51. Warfarin compared with aspirin for older Chinese patients with stable coronary heart diseases and atrial fibrillation complications.
    Liu X; Huang H; Yu J; Cao G; Feng L; Xu Q; Zhang S; Zhou M; Li Y
    Int J Clin Pharmacol Ther; 2014 Jun; 52(6):454-9. PubMed ID: 24755126
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anticoagulation for chronic atrial fibrillation.
    Stern S; Altkorn D; Levinson W
    JAMA; 2000 Jun; 283(22):2901-3. PubMed ID: 10865248
    [No Abstract]   [Full Text] [Related]  

  • 53. The effect and safety of the antithrombotic therapies in patients with atrial fibrillation and CHADS score 1.
    Lee BH; Park JS; Park JH; Park JS; Kwak JJ; Hwang ES; Kim SK; Choi DH; Kim YH; Pak HN
    J Cardiovasc Electrophysiol; 2010 May; 21(5):501-7. PubMed ID: 20021521
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Atrial fibrillation and thromboembolic events prevention. State of the art].
    Matteoli S; Trappolini M; Chillotti FM
    Minerva Cardioangiol; 2001 Feb; 49(1):1-13. PubMed ID: 11279381
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study.
    Homma S; Sacco RL; Di Tullio MR; Sciacca RR; Mohr JP;
    Circulation; 2002 Jun; 105(22):2625-31. PubMed ID: 12045168
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Warfarin or aspirin for recurrent ischemic stroke.
    Butera G; Chessa M; Carminati M
    N Engl J Med; 2002 Apr; 346(15):1169-71. PubMed ID: 11951856
    [No Abstract]   [Full Text] [Related]  

  • 57. Anticoagulants for prevention of ischemic stroke: current concepts.
    Mohr JP
    Adv Neurol; 2003; 92():263-70. PubMed ID: 12760192
    [No Abstract]   [Full Text] [Related]  

  • 58. Long term anticoagulation or antiplatelet treatment. Only warfarin has been shown to reduce stroke risk in patients with atrial fibrillation.
    Cleland JG; Kaye GC
    BMJ; 2001 Jul; 323(7306):233; author reply 235-6. PubMed ID: 11496885
    [No Abstract]   [Full Text] [Related]  

  • 59. Anticoagulation for atrial fibrillation in the elderly.
    Halperin JL
    Am J Geriatr Cardiol; 2005; 14(2):81-6. PubMed ID: 15785149
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Incidence of new thromboembolic stroke in persons 62 years and older with chronic atrial fibrillation treated with warfarin versus aspirin.
    Aronow WS; Ahn C; Kronzon I; Gutstein H
    J Am Geriatr Soc; 1999 Mar; 47(3):366-8. PubMed ID: 10078902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.